Capella, Inc.: Series C $17.3M

Posted in I - Series C, Q - 2Q09, R - INTERNATIONAL, X - Device (Cardiology), X - Device (Stent), X - Device (Vascular)

Capella (Ireland) a development-stage medical device company focused on stents for bifurcation vascular disease complex coronary artery disease, cloased a $17.3M Series C financing. Participants include Fountain Healthcare Partners, Mitsui & Co., Enterprise Ireland, Polytechnos Partners and ACT Venture Capital.

Jun

2009

Pathway Medical Technologies, Inc. Series D $42.5M

Posted in I - Series D, Q - 2Q09, R - NORTH WEST, X - Device (Vascular), X - PAD, XX - WA

Pathway Medical Technologies (Kirkland, WA) development-stage medical company focused on peripheral-arterial disease, closed a $42.5M Series D financing. Participants include HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners, Giza Venture Capital and WRF Capital.

Jan

2009

Concentric Medical, Inc.: Series D $15M

Posted in I - Series D, Q - 1Q09, R - WEST, X - Device (Catheter), X - Device (Vascular), XX - CA

Concentric Medical (Mountain View, CA) a commercial-stage medical device company commercializing products for the restoration of blood flow in patients who are experiencing an ischemic stroke, closed a $15M Series D financing. Participants include New Enterprise Associates.

Dec

2008

Tactile Systems Technology, Inc.: Series A $15.8M

Posted in I - Series A, Q - 4Q08, R - MID WEST, X - Device (Vascular), X - Lymphedema

Tactile Systems Technology (Minneapolis, MN) developer of medical devices for the treatment of lymphedema and vascular disease, closed a $15.8M Series A financing. Participatns include Galen Partners.

Nov

2008

Cardiva, Inc.: Series D $15.5M

Posted in I - Series D, Q - 2Q08, R - WEST, X - Device (Vascular)

Cardiva Medical (Mountain View, Calif.) medical device company focused on vascular closure, closed a $15.5M Series D financing. Participants include PTV Sciences, Galen Partners, Sycamore Ventures, Amkey Ventures, Lexli Investment, and Eminent Venture Capital.

Nov

2008

Pathway Medical Technologies, Inc.: Series B $24.5M

Posted in I - Series B, Q - 2Q08, R - NORTH EAST, X - Device (Vascular), X - PAD

Pathway Medical Technologies (Kirkland, WA) development-stage medical company focused on peripheral-arterial disease, closed a $24.5M Series B financing. Participants include HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners and Giza Venture Capital.

to top of page...